Private Advisor Group’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDI
DTC
Private Advisor Group's CLDI Position: Q3 2026 in Review
Private Advisor Group sold out of Calidi Biotherapeutics (CLDI) in Q3 2026, closing a stake of 1,875 shares — an estimated $5.1K sold.
Private Advisor Group first reported a position in CLDI in Q2 2026 and held it in 1 quarter. The position peaked at $5.1K in Q2 2026. 20 funds tracked by Wall St. Rank hold CLDI as of Q3 2026.
- Private Advisor Group reported no remaining Calidi Biotherapeutics position as of Q3 2026 after selling out during the quarter.
- Private Advisor Group sold 1,875 Calidi Biotherapeutics shares in Q3 2026, an estimated $5.1K.
- Private Advisor Group first reported a position in Calidi Biotherapeutics in Q2 2026 and held it in 1 quarter.
- Private Advisor Group's Calidi Biotherapeutics position peaked at $5.1K in Q2 2026.
- 20 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2026.
Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.